Colgate-Palmolive Total Cost of Revenue increased by 0.7% to $2.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $1.92B to $2.10B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.70B | $1.79B | $1.84B | $1.83B | $1.93B | $1.91B | $2.06B | $2.06B | $2.04B | $2.04B | $2.00B | $2.03B | $1.99B | $1.96B | $1.96B | $1.92B | $2.04B | $2.08B | $2.08B | $2.10B |
| QoQ Change | — | +5.1% | +3.0% | -0.9% | +5.6% | -1.2% | +7.8% | +0.1% | -1.1% | +0.1% | -1.9% | +1.3% | -1.7% | -1.7% | +0.2% | -2.0% | +6.1% | +2.0% | +0.1% | +0.7% |
| YoY Change | — | — | — | — | +13.3% | +6.5% | +11.4% | +12.6% | +5.4% | +6.9% | -2.7% | -1.6% | -2.1% | -3.9% | -1.8% | -5.0% | +2.5% | +6.3% | +6.2% | +9.0% |
| Segment | Q1 '25 | Q1 '26 |
|---|---|---|
| Pet Nutrition | $437.00M | $455.00M |
| Total | $1.92B | $2.10B |